Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
Emergent BioSolutions (NYSE: EBS) will report first quarter 2026 financial results and host a conference call on April 30, 2026 at 5:00 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Emergent BioSolutions (NYSE: EBS) will report first quarter 2026 financial results and host a conference call on April 30, 2026 at 5:00 p.m. ET.
Investors can join via live webcast on the company Investors page or register for telephone access; a replay will be posted on the Investors page.
Details
News Market Reaction – EBS
On Apr 17, the first trading day after this news, EBS closed 2.20% above the previous close.
Data tracked by StockTitan Argus for the Apr 17 session.
Key Figures
- Earnings call date
- April 30, 2026
- Q1 2026 financial results conference call
- Earnings call time
- 5:00 p.m. ET
- Start time for Q1 2026 results discussion
- Quarter reported
- First quarter 2026
- Period to be discussed on upcoming call
Previous Earnings date Reports
-
Scheduled Q4 and full-year 2025 earnings call with webcast access details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 30, 2026, at 5:00 p.m. eastern time to discuss the financial results for the first quarter of 2026.
Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.